Asahi Life Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Asahi Life Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,300	Closed	-$146K	–	294
2020 Q2	$146K	Sell	1,300 -2,740	-68%	-$291K	0.02%	195
2020 Q1	$363K	Buy	4,040 +180	+5%	+$17.7K	0.07%	112
2019 Q4	$417K	Buy	3,860 +1,700	+79%	+$182K	0.06%	132
2019 Q3	$212K	Buy	+2,160	New	+$243K	0.03%	164
2019 Q2	–	Sell	-3,310	Closed	-$447K	–	245
2019 Q1	$447K	Sell	3,310 -770	-19%	-$95.7K	0.07%	114
2018 Q4	$397K	Buy	+4,080	New	+$482K	0.06%	126

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Asahi Life Asset Management's ALXN Position: Q3 2020 in Review

Asahi Life Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2020, closing a stake of 1,300 shares — an estimated $146K sold.

Asahi Life Asset Management first reported a position in ALXN in Q4 2018 and held it in 6 quarters. The position peaked at $447K in Q1 2019. 707 funds tracked by Wall St. Rank hold ALXN as of Q3 2020.

Asahi Life Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Asahi Life Asset Management sold 1,300 Alexion Pharmaceuticals shares in Q3 2020, an estimated $146K.
Asahi Life Asset Management first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 6 quarters.
Asahi Life Asset Management's Alexion Pharmaceuticals position peaked at $447K in Q1 2019.
707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2020.

Based on Asahi Life Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.